Delhi High Court
1664 cases · page 6 of 56
Showing 151–179Grey Swift Private Limited Through Mr. Shivam Singla v.The Registrar Of Trade Marks
Grey Swift Private Limited has appealed a rejection order from the Senior Examiner of Trade Marks regarding its wordmark 'BharatStamp' in Class 9. The examiner rejected the mark, citing lack of distinctive character under Section 9(1)(a) of the Trade Marks Act. The Delhi High Court accepted the appeal and issued notice to the Registrar of Trade Marks, setting a date for arguments on August 28, 2024.
Diageo Scotland Limited v.Prachi Varma & Anr.
Diageo Scotland Limited successfully appealed against the rejection of its opposition to a new trademark registration, 'CAPTAIN BLUE'. The Delhi High Court ruled in favor of Diageo, finding that 'CAPTAIN BLUE' was deceptively similar and constituted an imitation of Diageo's established family of marks, particularly 'CAPTAIN MORGAN'. The court set aside the previous order and directed the removal of the infringing mark from the Register, reinforcing the protection afforded to well-known brands.
Epifi Technologies Private Limited v.Formula One Licensing Bv & Anr.
The Delhi High Court allowed a rectification petition filed by Epifi Technologies Private Limited against Formula One Licensing Bv & Anr., successfully arguing that the respondent's registered mark 'F1' should be removed from the register. The court found that the impugned mark had not been used in commerce for the required continuous period, and furthermore, the respondent failed to obtain necessary regulatory approvals despite its registration date. This decision reinforces the principle that trademark registrations must reflect genuine commercial use.
Hamdard Laboratories India (Medicine Division) v.Unani Drugs Manufacturers Association (UDMA)
This appeal before the Delhi High Court involved Hamdard Laboratories India (Medicine Division) challenging an order that dismissed its applications for interim injunction. The core dispute centered on the use of the 'HAMDARD' trademark and associated products, particularly in relation to the Unani Drugs Manufacturers Association (UDMA). Hamdard alleged misleading claims by UDMA regarding market share and product categorization. However, the High Court ultimately dismissed the appeal, noting that the matter fundamentally involved a commercial dispute requiring adjudication by a specialized Commercial Court.
Hamdard Laboratories India Medicine Division v.Unani Drugs Manufacturers Association (UDMA)
Hamdard Laboratories India (Medicine Division) appealed against an order dismissing its applications, alleging that UDMA was misleading the public by claiming market dominance and associating Hamdard Food Division products with medicinal claims. The core dispute revolved around the scope of a Family Settlement Deed which divided the HAMDARD Group into Medicine and Food divisions, restricting their respective product lines. The Delhi High Court ultimately dismissed the appeal, noting that the matter fundamentally involved commercial disputes concerning IP rights and required adjudication by a competent Commercial Court.
Mankind Pharma Limited v.Preet Kamal Grewal And Anr.
Mankind Pharma Limited successfully petitioned the Delhi High Court for the removal of a conflicting trademark, 'KINDPAN,' registered by Respondent No. 1 in Class 5. The court ruled that the registration was unsustainable because Mankind is the prior adopter and well-known proprietor of the 'KIND' family of marks in the pharmaceutical sector. By allowing the petition, the High Court reinforced the principle that established goodwill and extensive use grant heightened protection to a trademark owner against confusingly similar registrations.
Glanbia Performance Nutrition Limited v.Hercules Nutra Pvt. Ltd. & Anr.
The Delhi High Court allowed a cancellation petition filed by Glanbia Performance Nutrition Limited against Hercules Nutra Pvt. Ltd., directing the removal of an identical trademark registration from the register. The court found that Glanbia was a prior user and adopter of the 'ON' mark for nutritional supplements, possessing immense goodwill in India since 2003. Given the deceptive similarity of the respondent's mark (including copying the swoosh arrow) and the identity of the goods, the registration was deemed dishonest and liable to be cancelled.
Ibibo Group Pvt Ltd. v.Satyendra Kumar Singh And Anr
The Delhi High Court allowed a rectification petition filed by Ibibo Group Pvt Ltd. against an infringing trademark registration. The petitioner, a major online travel platform operating under 'GOIBIBO', successfully argued that the respondent's registered mark was deceptively similar and likely to cause confusion among consumers. Given the petitioner's extensive goodwill and prior use since 2009, the Court directed the Trade Marks Registry to remove the conflicting registration.
Psychotropic India Limited v.Meridian Medicare Ltd And Anr.
The Delhi High Court allowed a rectification petition filed by Psychotropic India Limited against Meridian Medicare Ltd. The court found that Respondent No. 1 adopted the mark 'TROMA' with malafide intent, capitalizing on the goodwill established by the petitioner in the pharmaceutical sector. Given the prior use and distinctiveness of the petitioner's marks (TROMANIL, TROMA), the court ruled that the registration held by the respondent was contrary to the Trade Marks Act, leading to its cancellation.
Manash Lifestyle Private Limited v.Viraj Harjai & Anr.
The Delhi High Court granted rectification to Manash Lifestyle Private Limited, a major online beauty retailer operating under the mark 'PURPLLE'. The court cancelled two registrations held by the respondent for similar marks ('PURPLLE TREE/'), finding that the petitioner was the prior and continuous user. This decision underscores the importance of establishing genuine, long-standing market presence over mere application dates when challenging trademark validity.
Balar Marketing Pvt. Ltd. v.Lakha Ram Sharma Proprietor Of Kundan Cable India
The Delhi High Court allowed a petition filed by Balar Marketing Pvt. Ltd., setting aside an order that had stayed several ongoing trademark suits. The stay was granted by the Trial Court based on observations from a Division Bench judgment regarding rectification petitions. However, the High Court held that the reference to 'passing off' in the cited precedent was merely obiter dicta and not binding law. Consequently, all the consolidated suits were directed to proceed expeditiously for trial.
M/S. Mocemsa Care v.The Registrar Of Trade Marks
The Delhi High Court allowed an appeal filed by M/S. Mocemsa Care against the Registrar's refusal of a device mark registration. The court held that even if the mark comprises common English words, its composite and stylized arrangement makes it distinctive when viewed as a whole. Furthermore, the court dismissed the objection regarding insufficient invoices, noting that this issue was never raised in the initial examination report. Consequently, the application is now directed to proceed with advertisement.
Imax Healthcare Private Limited & Anr. v.Max Healthcare Institute Limited
The Delhi High Court addressed an appeal challenging the Commercial Court's handling of an interlocutory injunction request concerning trademark infringement. The court found that the lower court failed to consider the merits of the respondent's application, merely granting the injunction to implement a prior judgment. Consequently, the High Court remanded the matter back to the Commercial Court for a fresh, de novo decision on the interim injunction, ensuring all legal aspects are properly considered.
F. Hoffmann-La Roche Ag v.Natco Pharma Limited
F. Hoffmann-La Roche filed a suit alleging infringement of its species patent (IN 334397) for the drug Risdiplam, marketed as EVRYSDI®, by Natco Pharma Limited. The plaintiffs sought an interim injunction to restrain the defendant from manufacturing and selling the API. However, the court found that the defendant had raised a credible challenge regarding the validity of the patent. Considering the public interest in affordable medicine for rare diseases like SMA, the court dismissed the application for interim injunction, though it clarified that damages would be payable if the plaintiffs ultimately succeed in the trial.
Macleods Pharmaceuticals Ltd v.The Controller Of Patents & Anr.
The review petition was filed by Respondent No. 2 challenging the original judgment dated January 15, 2025. The core dispute revolved around whether raising a defense of invalidity in an infringement suit (Section 107) prevents the patentee from filing a separate revocation petition (Section 64).
Milliken And Company v.Controller Of Patents And Designs & Anr.
Milliken And Company appealed the Assistant Controller's order refusing to grant an Indian patent application. The appellant argued that the Controller failed to consider a crucial expert statement by Dr. Nathan A Mehl. The High Court found merit in the appeal, holding that foreign decisions are not binding and directing the matter back for fresh consideration.
Ciena Corporation v.Union Of India & Ors.
Ciena Corporation challenged the deemed abandonment of its Indian patent application, which was issued by the Patent Office due to failure to respond to a First Examination Report (FER). The petitioner argued that this lapse was solely attributable to an inadvertent mistake made by their patent agent. The Delhi High Court agreed with Ciena, holding that an applicant should not suffer consequences for the bona fide errors of their legal representatives or agents. Consequently, the court set aside the abandonment letter and restored the application, granting a final opportunity to prosecute the patent.
Kiranakart Technologies Private Limited v.Mohammad Arshad & Anr.
Kiranakart Technologies Private Limited filed a suit seeking the removal of an identical word mark, 'ZEPTO,' registered by Respondent No. 1 under Section 47 and 57 of the Trade Marks Act, 1999. The Petitioner uses 'ZEPTO' for instant grocery delivery services, while the Respondent holds the mark in Class 35 relating to mobile phone marketing. The court has initiated proceedings by issuing notices to all parties, setting the stage for a detailed examination of trademark conflict and consumer confusion.
Ds Drinks And Beverages Private Limited v.Hector Beverages Private Limited
The Delhi High Court dismissed the appeal filed by Ds Drinks And Beverages Private Limited, upholding the interim injunction granted to Hector Beverages Private Limited. The court found that despite differences in surrounding words and product types (energy drink vs. juice), the core mark 'SWING' is predominant and highly similar. Given that both products are allied and sold across the same counter, the court ruled that there is a clear likelihood of customer confusion, favoring the established goodwill of Hector Beverages.
Cellectis v.The Assistant Controller Of Patents And Designs
Cellectis appealed a refusal order by the Controller of Patents regarding its patent application for a method involving T-Cells. The appeal sought permission to file amended claims and complete specification. The court examined whether these amendments were permissible under Section 59 of the Patents Act.
Veekesy Rubber Industries Pvt Ltd. v.Kamal Bansal
The Delhi High Court allowed a rectification petition filed by Veekesy Rubber Industries Pvt Ltd. against Kamal Bansal, directing the removal of the registered trademark 'VKG'. The court found that 'VKG' was confusingly similar to the petitioner's prior and well-established mark 'VKC', which had been used since 1985 in respect of footwear. Crucially, the court noted that the respondent failed to demonstrate actual use of the impugned mark, leading it to conclude that the registration was obtained dishonestly to trade upon the petitioner's goodwill.
Adyar Gate Hotels Limited v.ITC Limited & Anr.
The Delhi High Court set aside an ex-parte interim injunction that had restrained Adyar Gate Hotels Limited from using the trademark 'Dakshin'. The court found that the Single Judge failed to appreciate that the appellant was independently using the mark since 2015 and had shifted premises recently. This decision allows the matter to proceed on merits, requiring the appellant to file a formal response before the case is heard fully.
Allied Blenders And Distillers Limited v.Boutique Spirit Brands Private Limited
The Delhi High Court ruled in favor of Allied Blenders And Distillers Limited, granting a permanent injunction against Boutique Spirit Brands Private Limited for trademark infringement. The court found that the defendant's mark 'MYRON' was deceptively similar to the plaintiff’s established brand 'KYRON,' particularly as both were used for French Brandy. Furthermore, the court cancelled the defendant's registered trademarks ('BSB MYRON') following rectification petitions, effectively protecting the plaintiff's market exclusivity.
The Regents Of The University Of California v.The Controller Of Patents
The Regents of the University of California appealed the refusal of their patent application concerning a recombinant Salmonella microorganism based live vaccine. The Controller argued that the broad scope of the claims led to two major issues: first, they potentially covered naturally occurring loss-of-function variants, making them non-patentable under Section 3(c) of the Patents Act; and second, the complete specification lacked sufficient disclosure and clarity for the wide range of organisms claimed. The Delhi High Court upheld the Controller's decision, dismissing the appeal on grounds of insufficient disclosure and non-patentability.
Koninklijke Philips Electronics N.V. v.Maj(Retd) Sukesh Behl & Anr
Koninklijke Philips Electronics N.V. initiated legal proceedings against Maj(Retd) Sukesh Behl and others concerning a Suit Patent related to an 8/16 modulation method used in data recording on discs. The court addressed complex issues, including the patent's validity under various sections of the Patents Act (such as novelty, sufficiency of disclosure, and non-patentability). Ultimately, after analyzing infringement claims and the defendants' conduct, the judgment focused on determining appropriate FRAND royalty rates for the patented technology.
Punjab Fc Private Limited v.Posshusa Apparels India Private Limited
Punjab Fc Private Limited filed a petition seeking the removal (rectification) of the 'PFC' trademark registered under application no. 4611789 in Class 25, which was held by Posshusa Apparels India Private Limited. The petitioner highlighted a prior favorable judgment regarding an identical device mark. The Court accepted notice and directed that formal notices be issued to all parties, setting timelines for filing replies and rejoinders before listing the matter further.
F Hoffmann-La Roche Ltd & Others v.Drugs Controller General of India & Others
The plaintiffs, innovators of biological drugs 'bevacizumab' (AVASTIN) and 'trastuzumab' (HERCEPTIN), filed suits against generic manufacturers (Hetero and Cadila) seeking permanent injunctions. The current judgment addresses applications for the disclosure and production of documents related to the defendants' regulatory approvals, arguing that the approvals were obtained by suppressing material facts.
F Hoffmann-La Roche Ltd v.Drugs Controller General Of India
The plaintiffs, innovators of biological cancer drugs 'bevacizumab' (AVASTIN) and 'trastuzumab' (HERCEPTIN), filed suits against the Drugs Controller General of India and associated defendants. The current judgment addresses applications seeking disclosure and production of documents related to the DCGI approvals granted to bio-similar versions of these drugs.
Vgx Pharmaceuticals Inc v.The Controller General Of Patents, Designs And Trademarks
Vgx Pharmaceuticals Inc challenged the refusal of its patent application concerning 'Electroporation Devices and Methods.' The appeal argued that the Assistant Controller's order was unreasoned, failing to provide a clear justification for rejecting the invention based on prior art D4 and D5. The Delhi High Court agreed, finding the impugned order cryptic and lacking necessary analysis regarding inventive step. Consequently, the court allowed the appeal, setting aside the refusal and remanding the matter back to the Patent Office for fresh consideration.
Mankind Pharma v.Lemford Biotech Pvt Ltd.
The Delhi High Court allowed a rectification petition filed by Mankind Pharma against Lemford Biotech Pvt Ltd., directing the removal of the trademark 'LENOKIND'. The court found that 'LENOKIND' was confusingly similar to Mankind Pharma’s established and well-known family of marks, particularly those containing the element 'KIND'. Given Mankind Pharma's extensive prior use, massive market presence in pharmaceuticals, and acquired goodwill, the registration of 'LENOKIND' was deemed liable for cancellation under Section 57 of the Trade Marks Act.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.